Product Information
MORPHINE SULF 20 MG/5 ML SOLN is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1196 per ML under NDC 00054023849. Its NADAC has been published 243 times since Nov 19, 2014.
FDA first approved this application on Mar 17, 2008. Its Orange Book therapeutic-equivalence code is AA.
Strength
20 mg/5mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054023849
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MORPHINE SULFATEApproval Type
New Drug (NDA)
FDA Application
NDA022195FDA Approved
3/17/2008
TE Code
AA
On Market Since
3/17/2008
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULF 20 MG/5 ML SOLN has been published 243 times since Nov 19, 2014, and over the history we have for it it has declined 3.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1196 per ML |
|---|---|
| All-time high | $0.1272 (Dec 11, 2024) |
| All-time low | $0.1196 (Sep 23, 2026) |
| 52-week high | $0.1241 |
| 52-week low | $0.1196 |
| Median price | $0.1248 |
| Average price | $0.1245 |
| Largest weekly change | -2.0% (Aug 20, 2025) |
| Weeks tracked | 243 |
| Tracking since | Nov 19, 2014 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 43% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Morphine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MORPHINE SULF 20 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULF 20 MG/5 ML SOLN, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1196 per ML (NDC 00054023849), effective Sep 30, 2026.
How has the price of MORPHINE SULF 20 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for MORPHINE SULF 20 MG/5 ML SOLN has declined 3.5%. It has been tracked across 243 weekly CMS publications since Nov 19, 2014.
What are the highest and lowest recorded NADAC prices for MORPHINE SULF 20 MG/5 ML SOLN?
Since Nov 19, 2014, the NADAC for MORPHINE SULF 20 MG/5 ML SOLN has ranged from a low of $0.1196 (Sep 23, 2026) to a high of $0.1272 (Dec 11, 2024), with a median of $0.1248 per ML.
Are there cheaper alternatives to MORPHINE SULF 20 MG/5 ML SOLN?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MORPHINE SULF 20 MG/5 ML SOLN, is $0.0682 per ML — about 43% below MORPHINE SULF 20 MG/5 ML SOLN.
Who manufactures MORPHINE SULF 20 MG/5 ML SOLN?
MORPHINE SULF 20 MG/5 ML SOLN (NDC 00054023849) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.